Maternal Risk of Cardiovascular Disease After Use of Assisted Reproductive Technologies.


Journal

JAMA cardiology
ISSN: 2380-6591
Titre abrégé: JAMA Cardiol
Pays: United States
ID NLM: 101676033

Informations de publication

Date de publication:
01 09 2023
Historique:
medline: 14 9 2023
pubmed: 9 8 2023
entrez: 9 8 2023
Statut: ppublish

Résumé

The use of assisted reproductive technologies (ARTs) is steadily increasing worldwide. The outcomes associated with treatment for an individual's long-term health, including risk of cardiovascular disease (CVD), remain largely unknown, due to the small number of studies and their limited follow-up time. To study whether the risk of CVD is increased among individuals who have given birth after ART compared with those who have given birth without ART. A registry-based cohort study was conducted using nationwide data from Denmark (1994-2014), Finland (1990-2014), Norway (1984-2015), and Sweden (1985-2015). Data analysis was conducted from January to August 2022. A total of 2 496 441 individuals with a registered delivery in the national birth registries during the study period were included, and 97 474 (4%) of these gave birth after ART. Data on ART conception were available from ART quality registries and/or medical birth registries. Information on CVD was available from patient and cause of death registries. The risk of CVD was estimated with Cox proportional hazards regression, adjusting for age, calendar year of start of follow-up, parity, diagnosis of polycystic ovary syndrome, diabetes, chronic hypertension, and country. Median follow-up was 11 (IQR, 5-18) years. The mean (SD) age of women with no use of ART was 29.1 (4.9) years, and the age of those who used ART was 33.8 (4.7) years. The rate of any CVD was 153 per 100 000 person-years. Individuals who gave birth after using ART had no increased risk of CVD (adjusted hazard ratio [AHR], 0.97; 95% CI, 0.91-1.02), with evidence of heterogeneity between the countries (I2 = 76%; P = .01 for heterogeneity). No significant differences in the risk of ischemic heart disease, cerebrovascular disease, stroke, cardiomyopathy, heart failure, pulmonary embolism, or deep vein thrombosis were noted with use of ART. However, there was a tendency for a modest reduction in the risk of myocardial infarction (AHR, 0.80; 95% CI, 0.65-0.99), with no notable heterogeneity between countries. The findings of this study suggest that women who gave birth after ART were not at increased risk of CVD over a median follow-up of 11 years compared with those who conceived without ART. Longer-term studies are needed to further examine whether ART is associated with higher risk of CVD.

Identifiants

pubmed: 37556134
pii: 2808015
doi: 10.1001/jamacardio.2023.2324
pmc: PMC10413220
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

837-845

Subventions

Organisme : British Heart Foundation
ID : CH/F/20/90003
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00032/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/6
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Auteurs

Maria C Magnus (MC)

Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.

Abigail Fraser (A)

Population Health Sciences, Bristol Medical School, Bristol, United Kingdom.
MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.

Siri E Håberg (SE)

Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway.

Kristiina Rönö (K)

Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Liv Bente Romundstad (LB)

Spiren Fertility Clinic, Trondheim, Norway.

Christina Bergh (C)

Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.

Anne Lærke Spangmose (AL)

Fertility Department, Copenhagen University Hospital, Rigshospitalet, Denmark, Copenhagen.

Anja Pinborg (A)

Fertility Department, Copenhagen University Hospital, Rigshospitalet, Denmark, Copenhagen.

Mika Gissler (M)

Finnish Institute for Health and Welfare, Helsinki, Finland, Region Stockholm, Academic Primary Health Care Centre, Stockholm, Sweden.
Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden.

Ulla-Britt Wennerholm (UB)

Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.

Bjørn Olav Åsvold (BO)

K. G. Jebsen Center for Genetic Epidemiology, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Endocrinology, Clinic of Medicine, St Olavs Hospital, Trondheim University 1 Hospital, Trondheim, Norway.

Deborah A Lawlor (DA)

Population Health Sciences, Bristol Medical School, Bristol, United Kingdom.
MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.

Signe Opdahl (S)

Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH